enthusiasm dramatically outpaces science FDA Category 2 classifications for peptides like Semax reflect absence of FDA-standard evidence, not documented harmsRussian clinical experience suggests reasonable safety, but long-term effects by Western standards remain uncharacterized Established interventionsexercise, Mediterranean diet, sleep optimization, cardiovascular risk management, cognitive engagementhave far more consistent evidence than any peptide for dementia risk reduction For Research Prioritization Compounds meriting continued investigation: GLP-1 Agonists: Prevention trials in preclinical/presymptomatic populations, testing compounds with better brain penetration (dulaglutide, lixisenatide) SS-31/Elamipretide: Cognitive outcomes in mitochondrial disease populations, potential expansion to brain aging indications P21: Phase I human trials to establish safety, pharmacokinetics, and proof-of-mechanism for CNTF-pathway neurogenesis Klotho: Watch for Phase 1 results from Jocasta Neuroscience (expected 2027-2028)

Imagine waking up each morning to see stubborn dark spots staring back at you from the mirror, reminders of sun damage or acne scars that refuse to fade despite trying countless products
Based on preliminary experiments with 26 maize inbred lines, we identified three maize lines (P39, B73, and Oh7B) that show significant differences in their resistance to the beet armyworm
Clinical features of bacterial conjunctivitis are bilateral at onset in 75% of cases with mucopurulent discharge, while viral is bilateral at onset in 35% of cases with watery discharge [165]
doi: 10.3390/cancers16081554 427 NurkolisFQhabibiFRYusufVMBulainSPradityaGNLailossaDGet al
The Future of Urban Detoxification As research into glutathione and detoxification continues to evolve, we're likely to see even more targeted approaches to combating urban toxicity